uNGAL is also monitored in CKD progression determined by IgA nephropathy [34] and systemic lupus erythematosus [56], while plasma NGAL is used to detect CKD progression in diabetic nephropathy [35]. Here, LCN2 is linked to IgA glomerulonephritis.